Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin alfa for RBC Transfusion Reduction in Germ Cell Tumors
NCT00204633Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Jul 2003
- Primary completion
- Dec 2008
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 2 trial of darbepoetin alfa in germ cell tumor (GCT), sponsored by University Hospital Tübingen. Started Jul 2003; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT00204633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00204633.